Medtronic plc (0Y6X.L)
USD 82.42
(-1.79%)
USD 82.42
(-1.79%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 39.56 Billion USD | 0.71% |
| 2022 | 39.28 Billion USD | 2.67% |
| 2021 | 38.26 Billion USD | -7.77% |
| 2020 | 41.48 Billion USD | 4.18% |
| 2019 | 39.81 Billion USD | 0.85% |
| 2018 | 39.48 Billion USD | -2.68% |
| 2017 | 40.57 Billion USD | -18.08% |
| 2016 | 49.52 Billion USD | 4.09% |
| 2015 | 47.58 Billion USD | -10.99% |
| 2014 | 53.45 Billion USD | 188.95% |
| 2013 | 18.5 Billion USD | 13.99% |
| 2012 | 16.22 Billion USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 41.58 Billion USD | 5.13% |
| 2023 Q4 | 39.56 Billion USD | 1.85% |
| 2023 FY | 39.56 Billion USD | 0.71% |
| 2023 Q1 | 39.41 Billion USD | 0.33% |
| 2023 Q3 | 38.84 Billion USD | 1.05% |
| 2023 Q2 | 38.43 Billion USD | -2.47% |
| 2022 Q3 | 42.51 Billion USD | 3.23% |
| 2022 Q1 | 37.07 Billion USD | -3.1% |
| 2022 FY | 39.28 Billion USD | 2.67% |
| 2022 Q4 | 39.28 Billion USD | -7.61% |
| 2022 Q2 | 41.18 Billion USD | 11.09% |
| 2021 Q1 | 40.13 Billion USD | -3.24% |
| 2021 Q3 | 39.09 Billion USD | -1.27% |
| 2021 Q4 | 38.26 Billion USD | -2.13% |
| 2021 Q2 | 39.59 Billion USD | -1.35% |
| 2021 FY | 38.26 Billion USD | -7.77% |
| 2020 Q1 | 43.46 Billion USD | 9.16% |
| 2020 FY | 41.48 Billion USD | 4.18% |
| 2020 Q2 | 45.57 Billion USD | 4.85% |
| 2020 Q3 | 46.34 Billion USD | 1.69% |
| 2020 Q4 | 41.48 Billion USD | -10.49% |
| 2019 FY | 39.81 Billion USD | 0.85% |
| 2019 Q3 | 40.86 Billion USD | 1.33% |
| 2019 Q2 | 40.33 Billion USD | -1.07% |
| 2019 Q1 | 40.77 Billion USD | 3.26% |
| 2019 Q4 | 39.81 Billion USD | -2.57% |
| 2018 Q3 | 38.78 Billion USD | 0.92% |
| 2018 Q2 | 38.43 Billion USD | -2.43% |
| 2018 Q1 | 39.39 Billion USD | -3.15% |
| 2018 FY | 39.48 Billion USD | -2.68% |
| 2018 Q4 | 39.48 Billion USD | 1.79% |
| 2017 Q1 | 49.46 Billion USD | -0.31% |
| 2017 Q3 | 45.46 Billion USD | 6.02% |
| 2017 Q4 | 40.67 Billion USD | -10.53% |
| 2017 FY | 40.57 Billion USD | -18.08% |
| 2017 Q2 | 42.88 Billion USD | -13.31% |
| 2016 Q3 | 48.08 Billion USD | -0.06% |
| 2016 FY | 49.52 Billion USD | 4.09% |
| 2016 Q2 | 48.11 Billion USD | 0.85% |
| 2016 Q4 | 49.61 Billion USD | 3.19% |
| 2016 Q1 | 47.7 Billion USD | 0.27% |
| 2015 FY | 47.58 Billion USD | -10.99% |
| 2015 Q4 | 47.58 Billion USD | -8.3% |
| 2015 Q3 | 51.89 Billion USD | -1.49% |
| 2015 Q2 | 52.67 Billion USD | 1.66% |
| 2015 Q1 | 51.81 Billion USD | -3.06% |
| 2014 FY | 53.45 Billion USD | 188.95% |
| 2014 Q3 | 35.06 Billion USD | 81.26% |
| 2014 Q2 | 19.34 Billion USD | 5.66% |
| 2014 Q1 | 18.3 Billion USD | -1.05% |
| 2014 Q4 | 53.45 Billion USD | 52.47% |
| 2013 Q1 | 16.45 Billion USD | 1.38% |
| 2013 Q3 | 17.87 Billion USD | 0.86% |
| 2013 FY | 18.5 Billion USD | 13.99% |
| 2013 Q4 | 18.5 Billion USD | 3.48% |
| 2013 Q2 | 17.72 Billion USD | 7.73% |
| 2012 Q3 | 17.11 Billion USD | 0.0% |
| 2012 FY | 16.22 Billion USD | 0.0% |
| 2012 Q4 | 16.22 Billion USD | -5.17% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Phreesia, Inc. | 119.63 Million USD | -32967.806% |
| Accuray Incorporated | 423.54 Million USD | -9240.492% |
| Align Technology, Inc. | 2.45 Billion USD | -1512.505% |
| Elevance Health Inc. | 69.52 Billion USD | 43.097% |
| AxoGen, Inc. | 101.16 Million USD | -39006.582% |
| Boston Scientific Corporation | 15.6 Billion USD | -153.499% |
| CVS Health Corporation | 173.09 Billion USD | 77.145% |
| Cardinal Health, Inc. | 48.33 Billion USD | 18.149% |
| Centene Corporation | 58.68 Billion USD | 32.588% |
| DaVita Inc. | 14.87 Billion USD | -165.936% |
| HCA Healthcare, Inc. | 55.15 Billion USD | 28.268% |
| Hologic, Inc. | 4.02 Billion USD | -882.638% |
| Humana Inc. | 30.74 Billion USD | -28.666% |
| IDEXX Laboratories, Inc. | 1.77 Billion USD | -2128.293% |
| Laboratory Corporation of America Holdings | 8.83 Billion USD | -347.796% |
| Masimo Corporation | 1.67 Billion USD | -2259.456% |
| McKesson Corporation | 69.04 Billion USD | 42.7% |
| Patterson Companies, Inc. | 1.89 Billion USD | -1987.652% |
| Quest Diagnostics Incorporated | 7.6 Billion USD | -420.266% |
| ResMed Inc. | 2 Billion USD | -1869.825% |
| Henry Schein, Inc. | 5.42 Billion USD | -629.908% |
| Teladoc Health, Inc. | 2.06 Billion USD | -1814.585% |
| Universal Health Services, Inc. | 8.15 Billion USD | -385.117% |
| Veeva Systems Inc. | 1.26 Billion USD | -3024.645% |
| Baxter International Inc. | 19.8 Billion USD | -99.722% |
| Becton, Dickinson and Company | 26.98 Billion USD | -46.609% |
| Intuitive Surgical, Inc. | 2.04 Billion USD | -1835.28% |
| Danaher Corporation | 30.99 Billion USD | -27.624% |
| Stryker Corporation | 21.31 Billion USD | -85.567% |